Wanda Health (also referred to as Wanda Connected Health) offers a digital remote patient monitoring platform that tracks individuals with chronic conditions such as diabetes and heart disease outside clinical settings. Its system combines connected devices, mobile apps and an analytics layer called the Insights Engine to surface actionable guidance for clinicians and users. Recent product releases include support programmes for GLP-1 weight-loss drug patients and an updated cardiometabolic app. Management reports that the company has beaten larger competitors to land several multi-million-dollar contracts and is experiencing double-digit monthly revenue growth. Wanda expects to exceed US$5 million in annual recurring revenue by the end of 2026. The firm is channelling new capital into accelerating work with major U.S. customers, advancing product development and scaling commercial execution. Post-round, EMV Capital values its 16.5 % stake in Wanda at £1.7 million, while third-party assets introduced by EMV now hold 29.6 % worth about £3.1 million.

Total raised

$5M

Funding rounds

5

Latest round

Equity

Latest activity

Dec 2025